Vishwas Seshadri insider trades
Open-market stock purchases and sales by Vishwas Seshadri, Chief Executive Officer at Abeona Therapeutics Inc, from SEC Form 4 filings since Jun 1, 2021.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +17%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 29, 2026 | ABEO Abeona Therapeutics Inc | Sold | $101K |
| Jul 9, 2026 | ABEO Abeona Therapeutics Inc | Sold | $473K |
| Jun 9, 2026 | ABEO Abeona Therapeutics Inc | Sold | $169K |
| Jun 8, 2026 | ABEO Abeona Therapeutics Inc | Sold | $133K |
| Mar 31, 2026 | ABEO Abeona Therapeutics Inc | Sold | $131K |
| Jan 22, 2026 | ABEO Abeona Therapeutics Inc | Sold | $372K |
| Jan 20, 2026 | ABEO Abeona Therapeutics Inc | Bought (not open market) | — |
| Dec 29, 2025 | ABEO Abeona Therapeutics Inc | Sold | $133K |
Companies traded
- ABEO Abeona Therapeutics Inc: 3 buys, 13 sales, last Sep 29, 2026